drugset / Trial / NCT07661758

Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section

NCT07661758

Phase 3 Recruiting 680 enrolled Tanta University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This prospective randomized controlled multicenter study will be conducted to evaluate the effects of pre-emptive IV lidocaine dose on the incidence and severity of intraoperative headache that may occur after the extra-abdominal manual uterine fundal pressure in patients undergoing cesarean section under spinal anesthesia.

Timeline

Start
2026-07-01
Primary completion
2026-11-01
Completion
2026-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications